VERSANT VENTURE MANAGEMENT, LLC
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | IPSC | 12.17M | $27.50M |
 | GLUE | 3.18M | $52.32M |
 | LENZ | 2.66M | $24.31M |
 | SKYE | 2.01M | $1.23M |
 | JBIO | 1.53M | $21.44M |
 | CTNM | 543K | $7.09M |
 | CRSP | 149K | $7.08M |
Century Therapeutics, Inc.
IPSC
Shares Held
12.17M
Value
$27.50M
Monte Rosa Therapeutics, Inc.
GLUE
Shares Held
3.18M
Value
$52.32M
LENZ Therapeutics, Inc.
LENZ
Shares Held
2.66M
Value
$24.31M
Skye Bioscience, Inc.
SKYE
Shares Held
2.01M
Value
$1.23M
Jade Biosciences, Inc.
JBIO
Shares Held
1.53M
Value
$21.44M
Contineum Therapeutics, Inc. Class A Common Stock
CTNM
Shares Held
543K
Value
$7.09M
CRISPR Therapeutics AG
CRSP
Shares Held
149K
Value
$7.08M